Science Explorer Back to mapMap
Discussion
Researcher · AZ Maria Middelares · Belgium

Christof Vulsteke

Christof Vulsteke publishes mostly in Oncology, Surgery and Pulmonary and Respiratory Medicine, on topics such as Cancer Immunotherapy and Biomarkers, Bladder and Urothelial Cancer Treatments and PARP inhibition in cancer therapy.

ORCID 0000-0002-4607-5660 OpenAlex
World rank
#313,241
of 7,710,434 ranked researchers
Rank in Belgium
#2,495
of 67,186
Works
202
Citations
8.9k
Citations per work
44.2
h-index
30
i10-index 61Top 11% in Oncology
Christof Vulsteke

What does Christof Vulsteke research?

Christof Vulsteke's work is mostly in Medicine (66%), Biochemistry, Genetics and Molecular Biology (3%).

Health Sciences: 134 works · 66.3% of their workMedicine: 134 works · 66.3% of their workOncology: 56 works · 27.7% of their workSurgery: 39 works · 19.1% of their workPulmonary and Respiratory Medicine: 21 works · 10.3% of their workReproductive Medicine: 11 works · 5.5% of their workObstetrics and Gynecology: 7 works · 3.7% of their workEverything else: 62 works · 30.6% of their workLife Sciences: 6 works · 3.1% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 3.1% of their workMolecular Biology: 6 works · 3.1% of their workTHEIR WORKChristof Vulsteke202works
Life Sciences3%Health Sciences66%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine13466.3%
  2. Everything else6230.6%
    1. Biochemistry, Genetics and Molecular Biology63.1%
  1. 1Oncology28% of their works
  2. 2Surgery19% of their works
  3. 3Pulmonary and Respiratory Medicine10% of their works
  4. 4Reproductive Medicine6% of their works
  5. 5Obstetrics and Gynecology4% of their works
  6. 6Molecular Biology3% of their works

Research topics

Which keywords describe Christof Vulsteke's research?

The keywords of their largest research topics: Chemotherapy, Neoadjuvant Therapy, Immune Checkpoint Blockade, PD-1 and PD-L1, Bladder Cancer, Urothelial Carcinoma, BRCA Mutation and PARP Inhibitors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Chemotherapy843 topics
  2. Neoadjuvant Therapy612 topics
  3. Immune Checkpoint Blockade561 topic
  4. PD-1 and PD-L1561 topic
  5. Bladder Cancer481 topic
  6. Urothelial Carcinoma481 topic
  7. BRCA Mutation261 topic
  8. PARP Inhibitors261 topic
  9. Genomic Analysis251 topic
  10. Ovarian Cancer251 topic
  11. Primary Urethral Carcinoma241 topic
  12. Urachal Carcinoma241 topic
  13. Cervical Cancer151 topic
  14. Endometrial Carcinoma151 topic
  15. Esophageal Carcinoma131 topic
  16. Preoperative Chemoradiotherapy131 topic
  17. Anthracyclines111 topic
  18. Doxorubicin111 topic

Where does Christof Vulsteke work?

Christof Vulsteke's main affiliation in the publication record is AZ Maria Middelares, Belgium.

How many publications and citations does Christof Vulsteke have?

OpenAlex counts 202 works and 8,919 citations for Christof Vulsteke, an h-index of 30, ranking #313,241 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Christof Vulsteke. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.